Sareum Holdings (SAR)


Latest News

Sierra Oncology to Present at ASCO Annual Meeting

RNS Number: 1423G Sareum Holdings PLC 25 May 2017 (AIM: SAR) 25 May 2016 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Sierra Oncology to Present Chk1 Clinical Trial Enhancements at ASCO Annual Meeting Sareum Holdings plc (AIM:SAR), the specialist cancer drug discovery and development company, notes an announcement made by Sierr...

Sareum to Present at BioTrinity 2017

RNS Number: 4772E Sareum Holdings PLC 09 May 2017 9 May 2017 Sareum Holdings PLC ("Sareum" or the "Company") Sareum to Present at BioTrinity 2017 Dr Tim Mitchell, CEO of Sareum Holdings plc (AIM:SAR) , the specialist cancer drug discovery and development business , will be giving two presentations at BioTrinity 2017 currently being held at the Nov...

Director Deals - Sareum Holdings PLC (SAR)

Dr Stephen Parker, Chairman, bought 1,136,221 shares in the company on the 8th March 2017 at a price of 0.95p. The Direct...

Director Shareholding

RNS Number: 9294Y Sareum Holdings PLC 09 March 2017 (AIM: SAR) 9 March 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Director shareholding Sareum announces that Dr. Stephen Parker, Sareum's Chairman, and his wife purchased 461,949 and 674,272 shares at 0.95p each respectively yesterday. These are the only shares that Dr Parker or his ...

All News

25-05-17Sierra Oncology to Present at ASCO Annual MeetingRNS
09-05-17Sareum to Present at BioTrinity 2017RNS
09-03-17Director Deals - Sareum Holdings PLC (SAR)StockMarketWire
09-03-17Director ShareholdingRNS
20-02-17Sareum swings to H1 pretax profitStockMarketWire
20-02-17Half-year ResultsRNS
09-02-17Notice of Interim ResultsRNS
09-01-17Milestone Payment from Chk1 Licence AgreementRNS
22-12-16Result of General MeetingRNS
15-12-16Result of AGMRNS
06-12-16Directors' Remuneration & General MeetingRNS
29-11-16Sareum to Present at AACR-NCI-EORTC ConferenceRNS
21-11-16Notice of AGMRNS
02-11-16Sareum Holdings narrows FY pretax lossStockMarketWire
02-11-16Final ResultsRNS
24-10-16Sareum says TYK2 feasibility study successfulStockMarketWire
24-10-16Successful Outcome from TYK2 Feasibility StudyRNS
17-10-16Sareum notes Japan, Singapore Patent GrantsStockMarketWire
17-10-16Japan and Singapore Patent GrantsRNS
27-09-16Banks keep FTSE in the red StockMarketWire
27-09-16Licence agreement for Chk1 Inhibitor CCT245737RNS
03-08-16Sareum confirms patent grants for Aurora+FLT3StockMarketWire
03-08-16China & HK Patent Grants for Sareum's Aurora+FLT3RNS
28-07-16Sareum comments on share-price moveStockMarketWire
28-07-16Movement in share priceRNS
23-05-16Clinical Trials CHK1 Inhibitor CCT245737 to OpenRNS
17-05-16Sareum appoints Stephen Parker as chairmanStockMarketWire
17-05-16Change of DirectorRNS
05-04-16FTSE falls on resources as Wall St, Europe dropStockMarketWire
05-04-16Should You Buy Blinkx Plc, Electrocomponents plc And Sareum Holdings Plc On Today’s News?Motley Fool
05-04-16Sareum's winStockMarketWire
05-04-16FTSE extends falls on resources; Europe tumblesStockMarketWire
05-04-16CHK1 Approved for Clinical TrialsRNS
24-03-16Sareum raises GBP1.1m via placingStockMarketWire
17-03-16Why Traders Are Moving Goodwin plc And Sareum Holdings Plc TodayMotley Fool
14-03-16Issue of OptionsRNS
10-03-16Sareum notes share price movementStockMarketWire
10-03-16Share price movementRNS
24-02-16Sareum Holdings narrows H1 pretax lossStockMarketWire

RSS feeds

  • Editorial news feed for LSE:SAR Editorial
  • Regulatory news feed for LSE:SAR Regulatory